![Nathaniel Horwitz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nathaniel Horwitz
Gründer bei
GentiBio, Inc.
Profil
Nathaniel Brooks Horwitz is the founder of Avilar Therapeutics, Inc., founded in 2019.
Mr. Horwitz is the founder of Hunterbrook Capital LP, founded in 2023, and holds the title of Chief Executive Officer since 2023.
Mr. Horwitz was the founder of Nivien Therapeutics Co., founded in 2016, and served as Chief Executive Officer from 2016 to 2018.
Mr. Horwitz is the founder of GentiBio, Inc., founded in 2020, and holds the title of Director since 2020.
Mr. Horwitz is also the founder of Hunterbrook Media LLC.
Mr. Horwitz currently holds the position of Director at Superluminal Medicines, Inc. Mr. Horwitz is Principal at RA Capital Management LP (Private Equity) since 2019.
Formerly, Mr. Horwitz was Director at New Equilibrium Biosciences, Inc. Mr. Horwitz completed undergraduate studies at Harvard University in 2018.
Aktive Positionen von Nathaniel Horwitz
| Unternehmen | Position | Beginn |
|---|---|---|
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement. | Private-Equity-Analyst | 01.06.2019 |
GentiBio, Inc.
 GentiBio, Inc. BiotechnologyHealth Technology Develops regulatory T-cells for allergic diseases | Gründer | 01.01.2020 |
Avilar Therapeutics, Inc.
 Avilar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops covalent drugs to treat cancer and other autoimmune diseases | Gründer | 01.01.2019 |
Superluminal Medicines Inc
 Superluminal Medicines Inc BiotechnologyHealth Technology Operates as a generative biological and chemical company | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Nathaniel Horwitz
| Unternehmen | Position | Ende |
|---|---|---|
Nivien Therapeutics Co.
 Nivien Therapeutics Co. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Vorstandsvorsitzender | 31.12.2018 |
New Equilibrium Biosciences, Inc.
 New Equilibrium Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Direktor/Vorstandsmitglied | - |
Ausbildung von Nathaniel Horwitz
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
47
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement. | Finance |
New Equilibrium Biosciences, Inc.
New Equilibrium Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Nivien Therapeutics Co.
Nivien Therapeutics Co. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
GentiBio, Inc.
GentiBio, Inc. BiotechnologyHealth Technology Develops regulatory T-cells for allergic diseases | Health Technology |
Avilar Therapeutics, Inc.
Avilar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops covalent drugs to treat cancer and other autoimmune diseases | Commercial Services |
Superluminal Medicines Inc
Superluminal Medicines Inc BiotechnologyHealth Technology Operates as a generative biological and chemical company | Health Technology |
